Prinses Máxima Centrum voor Kinderoncologie logo

Manufacturing Specialist – Cell and Gene Therapy Unit

Prinses Máxima Centrum voor Kinderoncologie

Utrecht
Full-time
2-5 years experience
On-site

Key Skills

Clinical Cell Therapy Manufacturing
Aseptic cGMP Cell Culture
HSCT Manufacturing
CAR-T Manufacturing
T-Cell Processing
Gene Editing
Manufacturing Execution Systems
Electronic Quality Systems
SOP and Batch Record Management
Process Optimization
Tech Transfer
CAPA
Upstream and Downstream Manufacturing
Scientific and Technical Documentation
Cross-Functional Collaboration
English Communication

Job Description

Are you a dedicated and experienced Manufacturing Specialist ready to take on a pivotal role in the development of advanced cell and gene therapies? At the Princess Máxima Center for pediatric oncology, we are at the forefront of innovation, working to transform lives through cutting-edge cancer treatments. To further shape the CGU in this start-up phase, an exciting opportunity is available for an experienced and highly motivated Manufacturing Specialist to join the new Cell and Gene Therapy Unit team. This is your chance to make a real difference in a pioneering environment, contributing to breakthrough therapies that impact patients worldwide. About The Cell And Gene Therapy Unit The Princess Máxima Center is building a state-of-the-art facility where the primary focus will be the manufacturing of ATMPs. Alongside production, the CGU will play a vital role in translational research to advance and refine innovative therapies. Would you like to know what it's like to work in our CGU? Rachel shares more about her work in the Cell and Gene Therapy Unit in [this article](https://www.prinsesmaximacentrum.nl/en/parent-and-child/stories-from-the-maxima-center/rachel-had-leukemia-at-the-age-of-twelve-now-she-works-at-the-maxima-center). Your Key Responsibilities As a Manufacturing Specialist, you will play a key role in producing clinical cell therapy products, ensuring they meet stringent regulatory and accreditation standards. Your responsibilities include: Executing all tasks related to the manufacturing of clinical cell therapy products, ensuring production timelines are met. Organizing and managing human clinical biomanufacturing campaigns, delivering final cellular products for therapy. Supporting the planning and implementation of cGMP projects at both upstream and downstream levels to deliver advanced therapies to patients. Training team members on manufacturing processes and coordinating with stakeholders during tech transfer activities to implement new processes. Preparing and revising SOPs, Work Instructions, and Batch Records, as well as implementing digital solutions for electronic Batch Record management. Participating in the development of strategies to innovate production systems and optimize manufacturing processes. Identifying process optimization opportunities and driving improvements. Collaborating closely with QA colleagues to address manufacturing deficiencies and recommend CAPA for batch records. Contributing to the process development of new therapies and translating research findings into clinical products. Supporting the implementation of the Manufacturing Execution System (MES). Participate in the out-of-hours on-call duties of the CGU after appropriate period of training. Your Profile You are a motivated and resourceful professional, ready to embrace the challenges of manufacturing in a high-stakes environment. You excel in working collaboratively within multidisciplinary teams and are driven to innovate and deliver high-quality therapies. Additionally, you bring: A university degree in Biomedical, Life Sciences, or a related field. Hands-on experience in clinical cell therapy product manufacturing, ideally with HSCTs, CAR-T, T cells, gene editing, and aseptic cGMP cell culture techniques. Basic cell culture experience can be used to build up these skills. Foundational cell culture experience is sufficient, and these skills will be progressively developed into hands-on competencies in clinical cell therapy manufacturing, including HSCTs, CAR-T, T-cell processing, gene-editing workflows, and aseptic cGMP techniques. Proficiency with MES and electronic quality systems. Familiarity with basic digital documentation tools is desirable, and structured training will support the development of proficiency in Manufacturing Execution Systems (MES) and electronic quality management systems. Knowledge of the EU regulatory and accreditation framework for cellular therapy product production. Experience in creating and managing SOPs, batch manufacturing records (BMRs), and other documentation for clinical manufacturing. Prior experience drafting scientific or technical protocols provides strong transferable skills and will support the development of competence in creating and managing SOPs, batch manufacturing records (BMRs), and other documentation required for clinical manufacturing. A blend of analytical and practical problem-solving skills, with the ability to manage a varied workload effectively. Strong interpersonal skills, fostering collaboration and team success. A proactive mindset, with the ability to develop innovative solutions for complex challenges. Excellent verbal and written communication skills in English; proficiency in Dutch is a valuable asset. Working at the Princess Máxima Center We offer a full-time position (based on 36 hours a week) in a very stimulating and interactive environment. The contract will be initially for one year, with the possibility to extend upon satisfaction. Your gross monthly salary (FWG 55) will be based on your experience and background and will include 8,33% holiday allowance and 8,33 % end-of-year bonus. The Princess Máxima Center operates according to the collective labor agreement ‘CAO ziekenhuizen’. Candidates who do not yet meet all requirements but demonstrate strong motivation, transferable skills and a willingness to learn are also encouraged to apply. In such cases, the starting salary will be aligned with FWG 50. The training period will span a minimum of one year, with the exact duration depending on the candidate’s prior experience and transferable competencies. The Princess Máxima Center The Princess Máxima Center for Pediatric Oncology is an integrated hospital and research institute, which integrates healthcare, research and education on pediatric cancer, in a single location in Utrecht. Our institute aims to provide the highest level of care for all children with cancer, with optimal quality of life. The center brings together the best possible care and scientific research, creating a unique interdisciplinary institute for pediatric oncology in Europe. Sluitingsdatum: 6 december 2026

Core Responsibilities

Manufacture clinical cell therapy products in compliance with regulatory and accreditation standards, and coordinate biomanufacturing campaigns, cGMP projects, and tech transfers. Develop and improve manufacturing processes and documentation, support MES implementation, collaborate with Quality Assurance on deficiencies and CAPA, and contribute to translating research into clinical therapies.

Requirements

A university degree in Biomedical Sciences, Life Sciences, or a related field is required, along with cell culture experience and relevant knowledge of clinical cell therapy manufacturing, cGMP, EU regulatory frameworks, and manufacturing documentation. Candidates should have strong problem-solving, collaboration, and communication skills; foundational experience may be developed through a structured training period, and English proficiency is required while Dutch is an asset.

Benefits

  • Holiday Allowance
  • End-of-Year Bonus

About Prinses Máxima Centrum voor Kinderoncologie

Industry: Hospitals and Health Care

Company size: 1,001-5,000 employees

Het Prinses Máxima Centrum voor kinderoncologie is een uniek initiatief van ouders van kinderen met kanker en professionals in de kinderoncologie in Nederland om alle top-expertise op zorg- en onderzoeksgebied samen te voegen in één nationaal centrum. Dit is nodig omdat kanker nog steeds de meest voorkomende doodsoorzaak door ziekte is op jonge leeftijd en het genezingspercentage in de afgelopen 10 jaar nauwelijks is toegenomen. Concentratie van de behandeling van en het onderzoek naar alle vormen van kinderkanker in één centrum is een wezenlijke stap naar betere kwaliteit en hogere overlevingskansen.

Added Today